Recombinant Rat Stannin (Snn) is a synthetic protein produced through bacterial expression systems, primarily E. coli, and is engineered with an N-terminal His-tag for purification and functional studies. As a highly conserved vertebrate protein, Snn (UniProt ID: P61808) spans 88 amino acids and plays roles in cellular responses to stressors, including oxidative stress and toxicant exposure .
TNF-α-Induced Expression:
Chemical Interactions:
Membrane Localization: The GCWC motif suggests potential interaction with membrane-bound proteins or lipids .
Stress Response: Snn’s induction by TNF-α and toxins implies a protective or regulatory function in cellular stress adaptation .
Exact Molecular Mechanism: Direct binding partners and signaling pathways remain undefined.
In Vivo Relevance: Most studies focus on in vitro models; translational research is needed.
Structural Characterization: NMR/X-ray crystallography to resolve Snn’s tertiary structure.
Toxicity Biomarkers: Investigating Snn as a biomarker for arsenic or drug-induced toxicity.
Therapeutic Applications: Exploring Snn-targeted interventions in inflammation or neurodegenerative diseases.
Stannin (Snn) is an 88-amino acid protein that is highly conserved throughout vertebrate evolution . The rat Stannin sequence includes specific amino acid regions such as "CWCYLRLQR ISQSEDEESI VGDGETKEPF LLVQYSAKGP CVERKAKLMT ANSPEVHG," which represents amino acids 32-88 of the protein .
As a research methodology, structural analysis of Stannin typically employs techniques such as circular dichroism spectroscopy and NMR to determine secondary structure elements. When working with recombinant fragments, researchers should consider how the selected region (such as AA 32-88) might affect protein folding and functional capacity compared to the full-length protein.
Stannin demonstrates remarkable evolutionary conservation, suggesting essential biological roles. The rat and mouse Snn amino acid sequences are 100% identical, while the human Snn differs by only two amino acids at the C-terminus . At the nucleotide level, human and mouse Snn sequences share 90% identity .
This high degree of conservation can be investigated through comparative genomics approaches:
Multiple sequence alignment of Snn from different species
Phylogenetic analysis to establish evolutionary relationships
Identification of conserved domains that may indicate functional regions
Mutational analysis of conserved residues to determine their importance
The strong conservation suggests that Stannin plays fundamental roles in cellular processes that have been maintained through evolutionary pressure.
Several expression systems have been utilized for recombinant Rat Stannin production:
When selecting an expression system, researchers should consider:
Required post-translational modifications
Need for proper protein folding
Downstream applications (structural studies, functional assays)
Scale of production needed
For functional studies, mammalian expression systems may offer advantages for proper folding and modifications, though microbial systems can provide higher yields for structural studies.
Effective purification of recombinant Rat Stannin typically follows a multi-step approach:
Affinity chromatography using the fusion tag (e.g., His-tag, Fc-tag)
Size exclusion chromatography for further purification
Quality assessment using techniques such as:
Researchers should optimize buffer conditions to maintain protein stability, potentially including reducing agents if the sequence contains cysteine residues (as seen in the "CWCYLRLQR..." sequence) . Purity levels exceeding 90% are achievable and recommended for most research applications .
Stannin plays a significant role in tumor necrosis factor-α (TNF-α) signaling pathways. Research has demonstrated that Snn mRNA expression is induced by TNF-α treatment in a protein kinase C-ε (PKC-ε)-dependent manner in human umbilical vein endothelial cells (HUVECs) .
Methodologically, this relationship can be investigated by:
Treating cells with TNF-α and measuring Snn expression through quantitative RT-PCR
Using PKC-ε inhibitors to confirm the dependency of the signaling pathway
Performing Snn knockdown via siRNA prior to TNF-α treatment
Analyzing downstream effects on cell growth and gene expression profiles
Experimental evidence shows that Snn knockdown prior to TNF-α treatment results in significant inhibition of HUVEC growth compared to TNF-α treatment alone, suggesting Stannin mediates certain cellular responses to TNF-α .
Microarray analysis of TNF-α-stimulated HUVECs with and without Snn knockdown has revealed significant impacts on cell cycle regulation .
Key findings include:
Cell growth and maintenance genes represent 33% of significantly altered genes
Signal transduction genes account for 18.75% of altered genes
Nucleic acid metabolism genes make up 17.7% of altered genes
Specifically affected genes include IL-4, p29, PRKC/WT1, MDM4, PLA2, E-selectin, cdc42 binding protein, and human Ras-like suppressor, with IL-4, p29, and MDM4 having direct implications for cell cycle regulation .
For methodological investigation, researchers should:
Design specific siRNA targeting Snn with appropriate controls
Validate knockdown efficiency using qRT-PCR and Western blot
Perform microarray analysis or RNA-seq to identify affected pathways
Validate key targets using qRT-PCR
Assess functional outcomes through cell proliferation assays, cell cycle analysis, and apoptosis measurements
Several experimental approaches have proven effective for studying Stannin function:
Recombinant protein production strategies:
Functional characterization assays:
Binding assays to identify interaction partners
Cell-based assays using purified recombinant protein
In vitro enzymatic activity measurements if applicable
Structural studies:
Circular dichroism for secondary structure analysis
NMR or X-ray crystallography for detailed structural information
Mutation analysis of conserved residues
Complementation studies:
Rescue experiments in Snn-knockdown cells using recombinant protein
Structure-function relationship studies using domain deletions or point mutations
Stannin has been demonstrated to be necessary, but not sufficient, for trimethyltin (TMT) toxicity . This relationship provides an important research avenue for toxicology studies.
Methodological approaches to investigate this role using recombinant Stannin include:
Binding assays between recombinant Stannin and TMT
Structure-function studies using various Stannin mutants
Cell-based toxicity assays comparing wild-type and Snn-deficient cells
Rescue experiments introducing recombinant Stannin into Snn-knockout cells
Comparative analysis of TMT binding to Stannin from different species
Understanding the molecular basis of this interaction could provide insights into mechanisms of metal toxicity and potential therapeutic interventions.
Microarray analysis has been successfully employed to elucidate Stannin's role in cellular functions, particularly in relation to TNF-α signaling . A methodological framework for such analysis includes:
Experimental design:
Data analysis approach:
Functional categorization:
Group affected genes by biological process (cell growth, signal transduction, etc.)
Perform pathway analysis to identify networks affected by Snn modulation
Validate key nodes in identified pathways through targeted experiments
This approach has successfully identified that Snn knockdown affects genes involved in cell growth and maintenance (33%), signal transduction (18.75%), and nucleic acid metabolism (17.7%) .
Evaluating biological equivalence between recombinant and native Stannin presents several methodological challenges:
Structural integrity verification:
Comparison of secondary/tertiary structure
Analysis of post-translational modifications
Assessment of oligomerization state
Functional equivalence testing:
TNF-α response modulation capacity
Cell growth effects
Trimethyltin toxicity mediation
Technical considerations:
Ensuring proper folding of recombinant protein (especially from bacterial systems)
Addressing potential effects of fusion tags on function
Developing relevant quantitative assays for functional comparison
Validation approaches:
Complementation studies in Snn-deficient systems
Competitive binding assays
Comparative proteomics to identify differential binding partners
Researchers must carefully consider these factors when designing experiments using recombinant Stannin to ensure biological relevance of their findings.